<DOC>
	<DOCNO>NCT01594736</DOCNO>
	<brief_summary>This prospective , randomized trial compare extent cover stent strut segment assess Optical Coherence Tomography ( OCT ) ORSIRO DES XIENCE PRIME DES , standard choice contemporary drug elute stent ( DES ) .</brief_summary>
	<brief_title>Intracoronary Stenting Angiographic Results : ORSIRO Stents Versus Xience PRIME Stents Assessed Optical Coherence Tomography</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Patients old age 18 ischemic symptom evidence myocardial ischemia presence â‰¥ 50 % stenosis locate native coronary vessel . Written , inform consent patient her/his legallyauthorized representative participation study . In woman childbearing potential negative pregnancy test mandatory . AHA type A , B1 B2 lesion . Lesion length &gt; 25 mm require stent length &gt; 28 mm Target lesion locate leave main trunk . Instent restenosis . Acute myocardial infarction Malignancies comorbid condition ( example severe liver , renal pancreatic disease ) life expectancy le 18 month may result protocol noncompliance . Known allergy study medication : sirolimus , everolimus Inability take dual antiplatelet therapy least 6 month . The presence bifurcation lesions The presence calcify lesion Pregnancy ( present , suspected plan ) positive pregnancy test . Previous enrollment trial . Patient 's inability fully cooperate study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>